Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
3-[2-[(4aS,7aR)-3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl]-4-[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methyl-benzamide
ID: ALA5220606
PubChem CID: 156560495
Max Phase: Preclinical
Molecular Formula: C27H32N6O3
Molecular Weight: 488.59
Associated Items:
This compound is not in our inventory system